Emergent BioSolutions Inc (EBS)

10.32 +0.05 (+0.49%) USD  |  NYSE  |  Jan 03, 16:00
10.24 -0.08 (-0.78%) After-Hours: 20:00
More

Emergent BioSolutions Total Long Term Debt (Quarterly): 662.60M for Sept. 30, 2024

Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for EBS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Debt Definition

View Total Long Term Debt Definition
Start Trial

Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 14.98B
Tonix Pharmaceuticals Holding Corp 7.992M
Chimerix Inc 0.00
Marinus Pharmaceuticals Inc 55.19M
MAIA Biotechnology Inc --